Open AccessDoes Participation in Psychosocial Treatment Augment the Benefit of Clozapine?
Author(s) -
Robert A. Rosenheck
Publication year - 1998
Publication title -
archives of general psychiatry
Language(s) - English
Resource type - Journals
eISSN - 1538-3636
pISSN - 0003-990X
DOI - 10.1001/archpsyc.55.7.618
Subject(s) - psychosocial , clozapine , schizophrenia (object oriented programming) , haloperidol , quality of life (healthcare) , rehabilitation , psychiatry , veterans affairs , medicine , clinical trial , randomized controlled trial , psychology , intervention (counseling) , antipsychotic , clinical psychology , physical therapy , psychotherapist , dopamine
This study examines the role of participation in psychosocial treatment as a mediator of the clinical effectiveness of clozapine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom